ATOSSA THERAPEUTICS, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
ATOSSA THERAPEUTICS, INC. (ATOS) had Lessee, Operating Lease, Liability, to be Paid, Year One of $0 as of 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2022-02-28
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $0.00.
- 2020-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $19.40K.
- 2020-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $19.40K.
- 2020-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $19.40K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-28 |
| 2020-12-31 | $19.40K 10-K · filed 2021-03-31 |
| 2020-09-30 | $19.40K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $19.40K 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |